Clinical Trials Logo

Schizophrenia, First-Episode clinical trials

View clinical trials related to Schizophrenia, First-Episode.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00157378 Active, not recruiting - Clinical trials for Schizophrenia, First-Episode

Optimization of Acute Treatment in First Episode Schizophrenia

Start date: November 2000
Phase: Phase 4
Study type: Interventional

The study is a multicenter, double-blind, randomized, parallel-group study with first episode schizophrenic patients. During a treatment phase of 8 weeks the patients are treated with Risperidone or Haloperidol. Aim of the project is to compare the effects of the atypical neuroleptic Risperidone with those of the conventional neuroleptic Haloperidol and to evaluate whether the assumed advantages of atypical neuroleptics compared to conventional neuroleptics are also present when both medications are administered in rather low daily dosages (min. 2 mg/d; max. 8 mg/d).